Takeaway: See below for access to the replay and materials links...

LIVE Q&A

Tom and Will discussed the Macro Quad framework, how we're using MicroQuad/estimate momentum trends for relevant ETFs (XLV, XHS, XHE) and our health care stocks, reviewed health care labor trends, and answered timely questions on ATIP, ONEM, AMN/CCRN, ACHC, and ARKG. If you have follow-up questions or feedback on anything just email .

CLICK HERE to watch and access the presentation materials

Replay: Hedgeye House Call + Q&A | March 7 | Health Care Macro + Quad Playbook - 3 7 2022 Mental Health

Time Stamps & Quick Notes

00:15 – Intro, Position Monitor Update (TXG new on the short side, GDRX mistake/bottom of long bench, doing more on ETFs)

02:06 – Estimate Trend Update & MicroQuads vs. Macro Quad Framework – why we have a short bias, how we’re using the MicroQuads for screening/idea generation or confirmation (BDX, BAX, TXG, EXAS)

08:09 – ETF Back Tests (XLV, XBI, XHE, XHS)

09:28 – Coming out of Omicron, non-COVID occupancy breaking out, critical staffing shortages still high, and health care labor demand at all-time highs; unemployment rate vs. pent-up demand (slides 9-16)

16:06 – Psych hospitals & mental health – shifting sites of care (inpatient losing), LFST provider tracker looks strong

18:10 – ONEM provider tracker (+ net adds)

18:52 – Staffing Shortages – impact on temp staffing and pricing

20:00 – ATIP update – therapist tracker

21:04 – Newer process (ETFs & Step-Outs – XBI, XLV; ABMD (+), DXCM (-))

25:40 – Factor Exposures (market cap, analyst ratings, etc.) and Forecast Algos

29:50 – Q&A

  • 30:00 – ATIP, refi rate and [misplaced] confidence in management
  • 37:00 – AMN, CCRN, capacity to meet health care demand
  • 42:40 – ONEM, primary care multiples, why we like hybrid care #flow matters
  • 46:40 – ACHC, why we’re still short
  • 54:30 – MicroQuad / Estimate Momentum Trend
  • 56:30 – ARKG playbook

As always, all data available upon request, and reach out to  with any inquiries.

Thomas Tobin
Managing Director


Twitter
LinkedIn

William McMahon
Analyst


Twitter
LinkedIn

Justin Venneri
Director, Primary Research


Twitter
LinkedIn